Bloomberg: Alphabet-backed Isomorphic Labs in talks to raise about $5 billion
Bloomberg, citing people familiar with the matter, reported that Isomorphic Labs, an AI drug discovery company under Alphabet, is in talks to raise about $5 billion in new funding. The round would value the company at roughly $50 billion, according to the report. The people said the financing has not been completed and terms could still change. Isomorphic Labs was spun out of Google DeepMind in 2021. The company uses the AlphaFold protein structure prediction model in drug development. Earlier this year, in May, it completed a $2.1 billion financing round led by Thrive Capital, with Alphabet and others participating. The latest fundraising discussions, if completed on the reported terms, would mark another major capital raise for the company.







